Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma

Laboratory Investigation

Volumn 79, Issue 1, 1999, Pages 39-47

  Mautino, Gisèle ^a   Henriquet, Corinne ^a   Gougat, Claire ^a   Le Cam, Alphonse ^b   Dayer, Jean Michel ^c   Bousquet, Jean ^a   Capony, Françoise ^a,b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ASTHMA; COLLAGENASES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0032919702     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Aas K (1981). Heterogeneity of bronchial asthma. Allergy 36:3-10.
2. American Thoracic Society (1995). Definitions, epidemiology, pathophysiology, diagnosis and staging. Am J Respir Crit Care Med 152:379-583.
3. Barnes PJ (1994). Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med 150:542-849.
4. Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, and Rosenwasser LJ (1992). Detection of alveolar macrophage-derived IL-1 beta in asthma: Inhibition with corticosteroids. J Immunol 149:3078-3082.
5. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, and Michel FB (1990a). Eosinophilic inflammation in asthma. N Engl J Med 323:1033-1039.
6. Bousquet J, Emonot A, Germouty J, Molina C, Montane F, Perrin-Fayolle M, Prud'homme A, Sabbah A, Taytard A, Dupont P, Godard P, and Michel FB (1990b). Double-blind multicenter study of cetirizine in grass-pollen-induced asthma. Ann Allergy 65:504-508.
7. Bousquet J, Lacoste J, Chanez P, Vic P, Godard P, and Michel F (1996). Bronchial elastic fibers in normal subjects and asthmatic patients. Am J Respir Crit Care Med 153: 1648-1654.
8. Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, and Roche WR (1990). Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 3:507-511.
9. Chanez P, Bousquet J, Couret I, Cornillac L, Barneon G, Vic P, Michel FB, and Godard P (1991). Increased numbers of hypodense alveolar macrophages in patients with bronchial asthma. Am Rev Respir Dis 144:923-930.
10. Chanez P, Vignola A, Albat B, Springall DR, Polak JM, Godard P, and Bousquet J (1996). Involvement of endothelin in mononuclear phagocyte inflammation in asthma. J Allergy Clin Immunol 98:412-420.
11. Chanez P, Vignola A, Paul-Eugène N, Dugas B, Godard P, Michel F, and Bousquet J (1994). Modulation by IL-4 of cytokine release from mononuclear phagocytes in asthma. J Allergy Clin Immunol 94:997-1005.
12. Cluzel M, Damon M, Chanez P, Bousquet J, Crastes-de-Paulet A, Michel FB, and Godard P (1987). Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol 80:195-201.
13. Crapo J, Barry B, Gehr P, Bachofen M, and Weibel E (1982). Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 126:332-337.
14. Everson MP and Chandler DB (1992). Changes in distribution, morphology, and tumor necrosis factor-α secretion of alveolar macrophage subpopulations during the development of bleomycin-induced pulmonary fibrosis. Am J Pathol 140:503-512.
15. Fujimoto N, Hosokawa N, Iwata K, Okada Y, and Hayakawa T (1994). A one-step sandwich immunoassay for human matrix metalloproteinase using monclonal antibodies. Ann NY Acad Sci 737:359-361.
16. Gosset P, Tsicopoulos A, Wallaert B, Vannimenus C, Joseph M, Tonnel AB, and Capron A (1991). Increased secretion of tumor necrosis factor α and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 88:561-571.
17. Hance AJ, Douches S, Winchester RJ, Ferrans VJ, and Crystal RG (1985). Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: Changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J Immunol 134:284-292.
18. Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, and Takehara K (1998). Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. J Rheumatol 25:308-313.
19. Hibbs MS, Hoidal JR, and Kang AH (1987). Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest 80:1644-1650.
20. Kissane JM and Robins E (1958). The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem 233: 184-189.
21. Kodama S, Iwat K, Yamashita K, and Hayakawa T (1990). Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases: An application for rhumatoid arthritis in serum and plasma. J Immunol Method 127:103-108.
22. Kovacs EJ and DiPietro LA (1994). Fibrogenic cytokines and connective tissue production. FASEB J 8:854-861.
23. La Fleur M, Underwood JL, Rappolee DA, and Werb Z (1996). Basement membrane and repair of injury to peripheral nerve: Defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 184:2311-2326.
24. Lacoste JY, Bousquet J, Chanez P, Van-Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, and Michel FB (1993). Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 92:537-548.
25. Lacraz S, Nicod L, Galve-de-Rochemonteix B, Baumberger C, Dayer JM, and Welgus HG (1992). Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 90:382-388.
26. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, and Dayer JM (1995). IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96:2304-2310.
27. Laitinen LA, Laitinen A, and Haahtela T (1993). Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 147:697-704.
28. Matrisian LM (1992). The matrix-degrading metalloproteinases. Bioessays 14:455-463.
29. Mautino G, Oliver N, Chanez P, Bousquet J, and Capony F (1997). Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 17:583-592.
30. Metzger WJ, Zavala D, Richerson HB, Moseley P, Iwamota P, Monick M, Sjoerdsma K, and Hunninghake GW (1987). Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: Description of the model and local airway inflammation. Am Rev Respir Dis 135:433-440.
31. Murphy G, Cockett Ml, Ward RV, and Docherty AJP (1991). Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: A quantitative comparison of the activities of 95 kDa and 75 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 277:277-279.
32. Ohno I, Ohtani K, Nitta Y, Suzuki J, Hoshi H, Honma M, Isoyama S, Tanno Y, Tamura G, Yamuchi K, Nagura H, and Shirato K (1997). Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airways. Am J Respir Cell Mol Biol 16:212-219.
33. Pluznik DH, Fridman R, and Reich R (1992). Correlation in the expression of type IV collagenase and the invasive and chemotactic abilities of myelomonocytic cells during differentiation into macrophages. Exp Hematol 20:57-63.
34. Poston RN, Chanez P, Lacoste JY, Litchfield T, Lee TH, and Bousquet J (1992). Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis 145:918-921.
35. Rankin JA (1989). The contribution of alveolar macrophages to hyperreactive airway disease. J Allergy Clin Immunol 83:722-729.
36. Ray A, LaForge K, and Sehgal P (1990). On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: Enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol 10:5736-5746.
37. Redington AE and Howarth PH (1997). Airway wall remodelling in asthma. Thorax 52:310-312.
38. Rennard SI, Hunninghake GW, Bitterman PB, and Crystal RG (1981). Production of fibronectin by the human alveolar macrophage: Mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci USA 78:7147-7151.
39. Roche WR, Beasley R, Williams JH, and Holgate ST (1989). Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1:520-524.
40. Sarén P, Welgus HG, and Kovanen PT (1996). TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 156:4159-4165.
41. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, and Welgus HG (1991). Human 92- and 72-kilodalton type iv collagenases are elastases. J Biol Chem 266:7870-7875.
42. Shapiro SD, Campbell EJ, Kobayashi DK, and Welgus HG (1991). Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue in-hibitor of metalloproteinase production by human alveolar macrophages. J Immunol 146:2724-2729.
43. Simeonova PP, Toriumi W, Kommineni C, Erkan M, Munson AE, Rom RN, and Luster MI (1997). Molecular regulation of IL-6 by asbestos in lung epithelial cells: Role of reactive oxygen species. J Immunol 159:3921-3928.
44. Stetler-Stevenson WG, Krutzsch HC, and Liotta LA (1989). Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374-17378.
45. Trocme C, Gaudin P, Berthier S, Barro C, Zaoui P, and Morel F (1998). Human B lymphocytes synthetise the 92-kDa gelatinase, matrix metalloproteinase-9. J Biol Chem 273: 20677-20684.
46. Van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, and Moldawer LL (1991). IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 146:3478-3482.
47. Warner JA, Julius P, Luttmann W, and Kroegel C (1997). Matrix metalloproteinases in bronchoalveolar lavage fluid following antigen challenge. Int Arch Allergy Immunol 113: 318-320.
48. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, and Goldberg GI (1990). Neutral metalloproteinases produced by human mononuclear phagocytes: Enzyme profile, regulation, and expression during cellular development. J Clin Invest 86:1496-502.
49. Woessner J Jr (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154.